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transplanted and all animals survived the length 
of the study. Two kidneys were allocated to the CI 
group, and two in the immediate transplantation 
(IT) group. On postoperative day four, Serum Cr and 
BUN were 2.7±0.3mg/dL and 16.5±0.5mg/dL in 
the CI group, and 2.0±0.45mg/dL and 14.5±0.5mg/
dL in the IT group respectively. 4-hour CrCl in the 
CI group was 19.3±0.77 mL/min and UPro 763±63 
mg/dL. In the IT group, CrCl was 34.1±2.85 mL/
min, and UPro 114.3±29.3mg/dL Conclusion: 
ECS can be used with thrombolytics to adequately 
resuscitate organs prior to transplantation in non-
anticoagulated (uncontrolled) DCD after 60 minutes 
of warm ischemia, and result in functional organs. 
Cold ischemia may be detrimental to DCD organs 
after procurement. 
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Introduction: Delayed graft function (DGF) occurs 
more frequently after kidney transplantation (KT) 
from donation after cardiovascular death (DCD) than 
from donation after brain death (DBD). In DBD-KT, 
DGF reduces graft survival. We investigated the effect 
of DGF on post-transplant outcomes in controlled 
DCD-KT. Patients and Methods: This single-center 
retrospective study recruited 80 controlled DCD-KT 
performed from January 2005 to December 2011. 
Mean follow-up was 28.5 months. Results: There 
was no primary non-function. DGF rate was 35.5%. 
Overall graft survivals in groups with and without 
DGF were 92.4% and 95.2% at 1 year, 92.4% and 
87.1% at 3 years, and 84.7% and 87.1% at 5 years, 
respectively (p= NS). Patients with and without DGF 
had the same survival rates at corresponding time 
points (92.4% and 97.2%, 92.4% and 93.9%, and 
84.7% and 93.9%, p=ns). Estimated glomerular 
filtration rate was significantly lower in DGF group 
at hospital discharge (29 vs 42 ml/min, p<0.01) 
and up to 6 months post-transplant (46 vs 52, 
p<0.05), but the difference disappeared afterward 
(47 vs 52 at 1 year, 50 vs 48 at 3 years, and 54 
vs 53 at 5 years, p=ns). DGF did not increase the 
risk of acute rejection (29.6% vs 30.6%, p=ns) or 
surgical complications (33.3% vs 26.5%, p=ns). 
DGF significantly prolonged hospitalization length 
in DGF compared to non-DGF patients (18.9 vs 13 
days, p<0.01). Donor BMI*30, recipient BMI*30 
and pre-transplant dialysis duration increased DGF 
risk in multivariate logistic regression analysis. 
Conclusions: DGF had no deleterious impact on 
controlled DCD-KT function. Comparable graft 
and patient survivals, renal function, rejection rate 
and surgical complications were observed between 
groups with and without DGF. DGF should be no 
longer considered as a medical barrier to controlled 
DCD-KT. 
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Introduction: The shortage of organs available for 
transplantation and rapid increase in the waiting 
lists has led to alternate strategies to expand the 
donor pool.Transplantation of two marginal kidneys 
into a single recipient can increase organ utilization. 
The aim of this study was to evaluate the early 
outcomes of dual renal transplants in our institution 
with a view of expanding the acceptance criteria 
for marginal donors. Methods: We retrospectively 
reviewed the data on all recipients who had 
cadaveric dual renal transplants from February 
2011 to October 2012.A total of 13 transplants 
were carried out, with 12 from DCD donors and 1 
from DBD donor. The selection criteria was based 
on the institutional guidelines,which include donors 
with an eGFR between 40-60,age less than 75 
years,cold ischaemic time(CIT)less than 24hours 
and primary warm ischaemic time less than 40 
minutes. Results: 11/13 kidneys were declined 
by 2 or more centers.The follow up period ranged 
from 2 weeks to 18 months. The mean CIT was 
12.43 hours for the first kidney and 14.44 hours of 
the second kidney. 46% experienced delayed graft 
function but became dialysis independent between 
4 and 56 days after transplantation.There has been 
1 graft failure due to focal segmental glomerular 
sclerosis (FSGS).There is a 100% patient survival 
and 92% graft survival rate of which 12/13 grafts 
still functioning. 77% of recipients achieved serum 
creatinine of less than 300 µmol/l at 3 months. 
Conclusion: We conclude that transplanting two 
marginal kidneys,otherwise destined to be discarded 
is an appropriate option for selected recipients. 
When donors are considered unsuitable as single 
kidney donors,dual kidney transplant should be 
cautiously considered. Previous authors have 
suggested using pre-implant histology scores to 
guide decision making, but this data demonstrates 
that clinical criteria may be sufficient. 
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